New molecular targeted EML4-ALK for lung cancer
Mano, H.
Gan to Kagaku Ryoho. Cancer and ChemoTherapy 36(8): 1268-1270
2009
ISSN/ISBN: 0385-0684 PMID: 19735110 Document Number: 632826
Document emailed within 1 workday
Related Documents
Shi, Y.; Sun, Y. 2015: Molecular targeted therapy of non-small cell lung cancer in China: the first 10 years Zhonghua Yi Xue Za Zhi 95(8): 564-569Nonomura, N.; Nakayama, M.; Takayama, H.; Nishimura, K.; Okuyama, A. 2008: Molecular-targeted therapy for prostate cancer Hinyokika Kiyo. Acta Urologica Japonica 54(1): 63-66
Hashimoto, Y.; Naruyama, H.; Ando, R.; Okada, S.; Tozawa, K.; Kohri, K. 2008: Molecular targeted therapy for prostate cancer Hinyokika Kiyo. Acta Urologica Japonica 54(1): 57-61
Wcisło, G. 2008: Molecular underpinnings of the targeted therapy for cancer Acta Poloniae Pharmaceutica 65(6): 633-640
Lea, P.; Ling, M. 2008: New molecular assays for cancer diagnosis and targeted therapy Current Opinion in Molecular Therapeutics 10(3): 251-259
Kato, S. 2013: New molecular-targeted agents for colorectal cancer - regorafenib and aflibercept Gan to Kagaku Ryoho. Cancer and ChemoTherapy 40(1): 6-9
Tenner, L.L.; O'Neil, B.H. 2014: Colorectal cancer and molecular targeted agents: progress--with caveats Oncology 28(2): 125; 128
Grothey, A. 2006: Recognizing and managing toxicities of molecular targeted therapies for colorectal cancer Oncology 20(14 Suppl 10: 21-28
Furuta, M.; Yokota, T. 2018: The Combination of Molecular Targeted Agents with Radiotherapy in Head and Neck Cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 45(3): 419-423
Tahara, M. 2008: Recent advances in molecular-targeted drugs in head and neck cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 35(5): 745-752
Okano, M.; Ohtake, T.; Saji, S. 2016: Combination Therapy of Molecular-Targeted Drugs for Breast Cancer -- their Potential in the Future Gan to Kagaku Ryoho. Cancer and ChemoTherapy 43(4): 398-403
Schreiber, G.; Pitterle, D.; Kim, Y.C.; Bepler, G. 1999: Molecular genetic analysis of primary lung cancer and cancer metastatic to the lung Anticancer Research 19(2a): 1109-1115
Herbst, R.S. 2002: Targeted therapy in non-small-cell lung cancer Oncology 16(9 Suppl 9: 19-24
Nakamura, Y.; Yamamoto, N. 2009: Second-line treatment and targeted therapy of advanced lung cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 36(5): 710-716
Kuo, H-Yang.; Yeh, K-Huei. 2014: Molecular-targeted therapy for chemotherapy-refractory gastric cancer: a case report and literature review Anticancer Research 34(7): 3695-3699
Shi, Y.; Sun, Y. 2014: The development trend of targeted therapy in non-small cell lung cancer Zhonghua Zhong Liu Za Zhi 36(7): 481-484
Wu, G.; Qian, G. 2014: Further intensifying researches on targeted therapy for non-small cell lung cancer Zhonghua Yi Xue Za Zhi 94(30): 2321-2323
Michiura, T.; Miyazaki, S.; Fujita, S.; Hirose, H.; Miyazaki, Y.; Sugimoto, S.; Yamabe, K.; Nagaoka, M. 2014: A case of advanced HER2- positive gastric cancer with a partial response to molecular targeted chemotherapy (S-1+CDDP+Trastuzumab) Gan to Kagaku Ryoho. Cancer and ChemoTherapy 41(12): 2346-2348
Moro-Sibilot, D.; Coudurier, M. 2009: Targeted therapies in second line treatment of metastatic non-small cell lung cancer La Revue du Praticien 59(7): 955-956
Muhammet Hacioglu, B.; Kostek, O.; Erdogan, B.; Uzunoglu, S.; Cicin, I. 2017: Targeted therapy with anaplastic lymphoma kinase inhibitors in non-small cell lung cancer even with brain metastasis Journal of Buon: Official Journal of the Balkan Union of Oncology 22(3): 586-591